These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 207496)

  • 21. Surgical therapy of glycogen storage disease.
    Boley SJ; Cohen MI; Gliedman ML
    Pediatrics; 1970 Dec; 46(6):929-33. PubMed ID: 5275633
    [No Abstract]   [Full Text] [Related]  

  • 22. Letter: Enhanced oxygen tension in the liver and serum-cholesterol-lowering effect of portacaval shunt in hyperlipidaemia.
    Stender S; Astrup P; Damgaard-Pedersen F
    Lancet; 1975 Oct; 2(7938):776. PubMed ID: 52813
    [No Abstract]   [Full Text] [Related]  

  • 23. Correction of neutropenia by portacaval shunt in type IB glycogen storage disease.
    J Pediatr; 1982 Jan; 100(1):168-9. PubMed ID: 6948944
    [No Abstract]   [Full Text] [Related]  

  • 24. Portal diversion for the treatment of glycogen storage disease in humans.
    Starzl TE; Putnam CW; Porter KA; Halgrimson CG; Corman J; Brown BI; Gotlin RW; Rodgerson DO; Greene HL
    Ann Surg; 1973 Oct; 178(4):525-39. PubMed ID: 4517839
    [No Abstract]   [Full Text] [Related]  

  • 25. Portacaval shunt in patients with familial hypercholesterolemia.
    Starzl TE; Chase HP; Ahrens EH; McNamara DJ; Bilheimer DW; Schaefer EJ; Rey J; Porter KA; Stein E; Francavilla A; Benson LN
    Ann Surg; 1983 Sep; 198(3):273-83. PubMed ID: 6615051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The hyperlipidemia in glycogen storage disease.
    Jakovcic S; Khachadurian AK; Hsia DY
    J Lab Clin Med; 1966 Nov; 68(5):769-79. PubMed ID: 5223987
    [No Abstract]   [Full Text] [Related]  

  • 27. [Nutritional therapy of glycogen storage disease types I and III].
    Moses SW; Phillip M; Bashan N
    Harefuah; 1987 Sep; 113(5-6):135-7. PubMed ID: 3121476
    [No Abstract]   [Full Text] [Related]  

  • 28. Portacaval shunt and hyperlipidemia.
    Starzl TE; Putnam CW; Koep LJ
    Arch Surg; 1978 Jan; 113(1):71-4. PubMed ID: 202223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Metabolic disorders of the liver.Part 2: glycogen storage diseases, hereditary fructose intolerance, galactosemia and hepatic porphyrias].
    Donner MG; Erhardt A; Häussinger D
    Dtsch Med Wochenschr; 2010 Dec; 135(50):2540-7. PubMed ID: 21140331
    [No Abstract]   [Full Text] [Related]  

  • 30. Glycogen storage diseases.
    Wolfsdorf JI; Weinstein DA
    Rev Endocr Metab Disord; 2003 Mar; 4(1):95-102. PubMed ID: 12618563
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term follow-up of portacaval shunt in glycogen storage disease type 1B.
    Corbeel L; Van Lierde S; Jaeken J
    Eur J Pediatr; 2000 Apr; 159(4):268-72. PubMed ID: 10789932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal nodular hyperplasia in an adolescent with glycogen storage disease type I with mesocaval shunt operation in childhood: a case report and review of the literature.
    Sakatoku H; Hirokawa Y; Inoue M; Kojima M; Yabana T; Sakurai M
    Acta Paediatr Jpn; 1996 Apr; 38(2):172-5. PubMed ID: 8677798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reappraisal of the Role of Portacaval Shunting in the Growth of Patients With Glycogen Storage Disease Type I in the Era of Liver Transplantation.
    Choi Y; Yi NJ; Ko JS; Moon JS; Suh SW; Lee JM; Jeong JH; Kim H; Lee HW; Lee KW; Suh KS
    Transplantation; 2016 Mar; 100(3):585-92. PubMed ID: 26360666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperlipidemia in glycogen storage disease type III: effect of age and metabolic control.
    Bernier AV; Sentner CP; Correia CE; Theriaque DW; Shuster JJ; Smit GP; Weinstein DA
    J Inherit Metab Dis; 2008 Dec; 31(6):729-32. PubMed ID: 18709545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haematological findings in type Ib glycogen storage disease before and after portacaval shunt.
    Corbeel L; Boogaerts M; Van den Berghe G; Everaerts MC; Marchal G; Eeckels R
    Eur J Pediatr; 1983; 140(3):273-5. PubMed ID: 6578929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Eck fistula in animals and humans.
    Starzl TE; Porter KA; Francavilla A
    Curr Probl Surg; 1983 Nov; 20(11):687-752. PubMed ID: 6357642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letter: Follow-up of patient with portacaval shunt for the treatment of hyperlipidaemia.
    Starzl TE; Chase HP; Putnam CW; Nora JJ
    Lancet; 1974 Sep; 2(7882):714-5. PubMed ID: 4142980
    [No Abstract]   [Full Text] [Related]  

  • 38. Portacaval shunt in four patients with homozygous hypercholesterolaemia.
    Stein EA; Pettifor J; Mieny C; Heimann KW; Spitz L; Bersohn I; Saaron I; Dinner M
    Lancet; 1975 Apr; 1(7911):832-5. PubMed ID: 48058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Difficult hGH treatment in a patient with type III glycogen storage disease.
    Larizza D; Maggiore G; Marzani D; Maghnie M; Ciceri R
    Eur J Pediatr; 1986 Apr; 145(1-2):84-5. PubMed ID: 3460808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. THE EFFECT OF PORTACAVAL TRANSPOSITION ON CARBOHYDRATE METABOLISM: EXPERIMENTAL AND CLINICAL OBSERVATIONS.
    STARZL TE; MARCHIORO TL; SEXTON AW; ILLINGWORTH B; WADDELL WR; FARIS TD; HERRMANN TJ
    Surgery; 1965 May; 57():687-97. PubMed ID: 14295780
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.